Leadership
Both our leadership team and board exemplify service and compassion in the name of science. Following their example,there’s no telling what we can become. But here’s one thing we do know: They won’t stop leading until we’ve made a meaningful difference in the lives of those who need it most.
-
Helen Wang, MS
Co-founder, Chairman, and CEO×Helen Wang, MS
Co-founder, Chairman, and CEO• Co-founded Youngene Therapeutics in 2016; currently Chairwoman and CEO
• Over 10 years of experience in management positions at multiple Chinese pharmaceutical companies including Henrui, Sundia, and ChemPartner
• Previous experience at the University of Chicago Medical Center and Sallie Mae USA
-
Yuan Wang, PhD
Co-Founder, VP of CMC×Yuan Wang, PhD
Co-Founder, VP of CMC• Co-founded Youngene Therapeutics in 2016; currently Vice President of CMC
• Founded 2-Y CHEM and 2-Y BIOPHARMA in 2004 and currently serves as Chairwoman and CEO
• Previous experience at DelMar Pharmaceuticals Canada and Linuo Pharmaceuticals
• PhD Organic Chemistry from Pierre and Marie Curie University (Paris 6)
-
Pablo Lapuerta, MD
Chief Medical Officer×Pablo Lapuerta, MD
Chief Medical Officer• Joined Youngene Therapeutics in 2019 as CMO
• 25 years of experience in the biotech industry and a track record of successful drug approvals
• Previously served as Chief Medical Officer at Lexicon Pharmaceuticals and Vice President of Clinical Development at Bristol-Myers Squibb
• Work has been published in leading scientific journals, including the New England Journal of Medicine
• MD from Harvard Medical School and a Bachelor’s degree in Biology from Harvard College where he graduated Summa Cum Laude
-
Jacky Li, PhD
COO and R&D VP×Jacky Li, PhD
COO and R&D VP• Joined Youngene Therapeutics in 2017 as Director of Research & Development
• Previous experience as research scientist at Hansoh Pharmaceuticals and GlaxoSmithKline (GSK) China
• PhD Biology from East China Normal University